Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa

Vincent Jamonneau, Oumou Camara, Hamidou Ilboudo, Moana Peylhard, Mathurin Koffi, Hassane Sakande, Louis N'Dri, Djénéba Sanou, Emilie Dama, Mamadou Camara, Veerle Lejon, Vincent Jamonneau, Oumou Camara, Hamidou Ilboudo, Moana Peylhard, Mathurin Koffi, Hassane Sakande, Louis N'Dri, Djénéba Sanou, Emilie Dama, Mamadou Camara, Veerle Lejon

Abstract

Background: Individual rapid tests for serodiagnosis (RDT) of human African trypanosomiasis (HAT) are particularly suited for passive screening and surveillance. However, so far, no large scale evaluation of RDTs has been performed for diagnosis of Trypanosoma brucei gambiense HAT in West Africa. The objective of this study was to assess the diagnostic accuracy of 2 commercial HAT-RDTs on stored plasma samples from West Africa.

Methodology/principal findings: SD Bioline HAT and HAT Sero-K-Set were performed on 722 plasma samples originating from Guinea and Côte d'Ivoire, including 231 parasitologically confirmed HAT patients, 257 healthy controls, and 234 unconfirmed individuals whose blood tested antibody positive in the card agglutination test but negative by parasitological tests. Immune trypanolysis was performed as a reference test for trypanosome specific antibody presence. Sensitivities in HAT patients were respectively 99.6% for SD Bioline HAT, and 99.1% for HAT Sero-K-Set, specificities in healthy controls were respectively 87.9% and 88.3%. Considering combined positivity in both RDTs, increased the specificity significantly (p ≤ 0.0003) to 93.4%, while 98.7% sensitivity was maintained. Specificities in controls were 98.7-99.6% for the combination of one or two RDTs with trypanolysis, maintaining a sensitivity of at least 98.1%.

Conclusions/significance: The observed specificity of the single RDTs was relatively low. Serial application of SD Bioline HAT and HAT Sero-K-Set might offer superior specificity compared to a single RDT, maintaining high sensitivity. The combination of one or two RDTs with trypanolysis seems promising for HAT surveillance.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Franco JR, Simarro PP, Diarra A, Ruiz Postigo JA, Jannin JG (2014) The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy. Parasitology 1–13.
    1. Magnus E, Vervoort T, Van Meirvenne N (1978) A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b.gambiense trypanosomiasis. Ann Soc Belg Méd Trop 58: 169–176.
    1. Sullivan L, Wall SJ, Carrington M, Ferguson MAJ (2013) Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a protoype lateral flow immunodiagnostic device. PLoS Negl Trop Dis 7: e2087 10.1371/journal.pntd.0002087
    1. Büscher P, Gilleman Q, Lejon V (2013) Novel rapid diagnostic test for sleeping sickness. N Engl J Med 368: 1069–1070. 10.1056/NEJMc1210373
    1. Lumbala C, Bisser S, Nguertoum E, Flevaud L, Jacquet D, et al. (2013) Development and evaluation of a rapid screening test for sleeping sickness. Annales Africaines de Médecine 6, Suppl. 1: 49.
    1. Jamonneau V, Bucheton B (2014) The challenge of serodiagnosis of sleeping sickness in the context of elimination. Lancet Glob Health 2: e306–e307. 10.1016/S2214-109X(14)70226-8
    1. Büscher P, Mertens P, Leclipteux T, Gilleman Q, Jacquet D, et al. (2014) Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. The Lancet Global Health.
    1. Truc P, Lejon V, Magnus E, Jamonneau V, Nangouma A, et al. (2002) Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bull World Health Organ 80: 882–886. S0042–96862002001100008 [pii]
    1. Simarro P, Cecchi G, Paone M, Franco JR, Diarra A, et al. (2010) The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 9: 57 10.1186/1476-072X-9-57
    1. World Health Organization (2013) Control and surveillance of human African trypanosomiasis. 984.
    1. Camara M, Camara O, Ilboudo H, Sakande H, Kaboré J et al. (2010) Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test. Trop Med Int Health 15: 796–799. 10.1111/j.1365-3156.2010.02546.x
    1. Gillet P, Bosselaers K, Cnops L, Bottieau E, van EM, Jacobs J (2009) Evaluation of the SD FK70 malaria Ag Plasmodium vivax rapid diagnostic test in a non-endemic setting. Malar J 8: 129 10.1186/1475-2875-8-129
    1. Bell DR, Wilson DW, Martin LB (2005) False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density. Am J Trop Med Hyg 73: 199–203.
    1. Van Meirvenne N, Magnus E, Büscher P (1995) Evaluation of variant specific trypanolysis tests for serodiagnosis of human infections with Trypanosoma brucei gambiense. Acta Trop 60: 189–199. 10.1016/0001-706X(95)00127-Z
    1. Jamonneau V, Bucheton B, Kaboré J, Ilboudo H, Camara O et al. (2010) Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in west Africa. PLoS Negl Trop Dis 4: e917–4.69. 10.1371/journal.pntd.0000917
    1. Bucheton B, MacLeod A, Jamonneau V (2011) Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol 33: 438–447. 10.1111/j.1365-3024.2011.01287.x
    1. Jamonneau V, Ilboudo H, Kaboré J, Kaba D, Koffi M et al. (2012) Untreated infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis 6: e1691 10.1371/journal.pntd.0001691
    1. World Health Organization (2009) HIV antigen/antibody assays: operational characteristics: report 16 rapid assays. Geneva: World Health Organization; 50 p.
    1. Camara O, Camara M, Lejon V, Ilboudo H, Sakande H et al. (2014) Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sickness. Trop Med Int Health 19: 828–831. 10.1111/tmi.12316
    1. Eperon G, Balasegaram M, Potet J, Mowbray C, Valverde O et al. (2014) Treatment options for second stage gambiense human African trypanosomiasis. Expert Rev Anti Infect Ther 12:1407–17. 10.1586/14787210.2014.959496

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi